Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a Phase II randomized, double-blind, placebo controlled, multi-site study of Candin. It is designed to show the efficacy and safety of a 7-dose regimen of Candin over a two-year period in terms of reducing cancer recurrence rate by comparing the recurrence rates between the Candin and the placebo arm. The ratio of the number of subjects who will receive Candin versus placebo will be 3:1. Up to 100 subjects will be screened until 80 subjects are eligible for injection.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Diagnoza raka płaskonabłonkowego głowy i szyi, po zakończeniu leczenia (operacja, napromienianie, chemioterapia) w ciągu ostatnich 120 dni
- •Brak widocznych śladów nowotworu w badaniach lekarskich i obrazowych
- •Zdolność do uczestnictwa w badaniu i wykonywania wymaganych wizyt
- •Zgoda na udział w badaniu
✗ Disqualifies
- •Pozytywny test ciążowy dla kobiet w wieku rozrodczym
- •Ciąża lub planowanie ciąży podczas badania
- •Karmienie piersią lub planowanie karmienia podczas badania
- •Alergia na Candin
- •Stan zdrowia, który w opinii lekarza stanowi poważne ryzyko dla uczestnika
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 100 Years
- Last updated (source)
- October 15, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (6)
Highlands Oncology Group, PA
Fayetteville, United States
University of Arkansas for Medical Sciences
Little Rock, United States
Highlands Oncology Group, PA
Rogers, United States
Highlands Oncology Group, PA
Springdale, United States
Perlmutter Cancer Center at NYU Langone Health
Mineola, United States
Perlmutter Cancer Center at NYU Langone Health
New York, United States
Trial contact
Emily Baker
Aaron Holley
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/16/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.